Home
>
National Drug Code (NDC)
>
Butalbital, Aspirin, Caffeine and Codeine Phosphate
Butalbital, Aspirin, Caffeine and Codeine Phosphate - 0591-3546-05 - (Butalbital, Aspirin, Caffeine and Codeine Phosphate)
Drug Information of Butalbital, Aspirin, Caffeine and Codeine Phosphate
| Product NDC: | 0591-3546 |
| Proprietary Name: | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
| Non Proprietary Name: | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
| Active Ingredient(s): | 325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1 & nbsp; Butalbital, Aspirin, Caffeine and Codeine Phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Butalbital, Aspirin, Caffeine and Codeine Phosphate
| Product NDC: | 0591-3546 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019429 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20070712 |
Package Information of Butalbital, Aspirin, Caffeine and Codeine Phosphate
| Package NDC: | 0591-3546-05 |
| Package Description: | 500 CAPSULE in 1 BOTTLE (0591-3546-05) |
NDC Information of Butalbital, Aspirin, Caffeine and Codeine Phosphate
| NDC Code | 0591-3546-05 |
| Proprietary Name | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
| Package Description | 500 CAPSULE in 1 BOTTLE (0591-3546-05) |
| Product NDC | 0591-3546 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20070712 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE |
| Strength Number | 325; 50; 40; 30 |
| Strength Unit | mg/1; mg/1; mg/1; mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
